Related content

Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients

By Solomon M.  

Digestive Diseases and Sciences, Vol. 56, Iss. 10, 2011-10 ,pp. : 3024-3031

Springer Publishing Company

Access to resources Recommend Favorite

Utilization and Antiviral Therapy in Patients with Chronic Hepatitis C: Analysis of Ambulatory Care Visits in the US

By Cheung Ramsey   Mannalithara Ajitha   Singh Gurkirpal  

Digestive Diseases and Sciences, Vol. 55, Iss. 6, 2010-06 ,pp. : 1744-1751

Springer Publishing Company

Access to resources Recommend Favorite

Shall We Treat All Patients with Hepatitis C, and if Not, Why? Certainly, Injecting Drug Users Must Not Be an Exclusion Criterion

By  

Digestion, Vol. 78, Iss. 2-3, 2008-11 ,pp. : 120-122

Karger

Access to resources Recommend Favorite

Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?

By Khokhar Omar   Lewis James  

Digestive Diseases and Sciences, Vol. 52, Iss. 5, 2007-05 ,pp. : 1168-1176

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Uptake of Patients with Chronic Hepatitis C: Can We Expect and Do More?

By Dai Chia-Yen  

Digestive Diseases and Sciences, Vol. 55, Iss. 12, 2010-12 ,pp. : 3300-3303

Springer Publishing Company

Access to resources Recommend Favorite